title: Chronic toxicity of chloroform to Japanese medaka fish.
abstract: Japanese medaka (Oryzias latipes) were continually exposed in a flow-through diluter system for 9 months to measured chloroform concentrations of 0.017, 0.151, or 1.463 mg/L. Parameters evaluated were hepatocarcinogenicity, hepatocellular proliferation, hematology, and intrahepatic chloroform concentration. Histopathology was evaluated at 6 and 9 months. Chloroform was not hepatocarcinogenic to the medaka at the concentrations tested. Chronic toxicity was evidenced at these time points by statistically significant ([alpha] = 0.05) levels of gallbladder lesions and bile duct abnormalities in medaka treated with 1.463 mg/L chloroform. We assessed hepatocellular proliferation by exposing test fish to 5-bromo-2'-deoxyuridine in the aquarium water for 72 hr after 4 and 20 days of chloroform exposure; we then quantified area-labeling indices of the livers using computer-assisted image analysis. We observed no treatment-related increases in cellular proliferation. We analyzed cells in circulating blood in medaka after 6 months of chloroform exposure. Hematocrit, leukocrit, cell viability, and cell counts of treated fish were not significantly different from those of control fish. Using gas chromatography (GC), we evaluated intrahepatic concentrations of chloroform in fish after 9 months of exposure. Livers from the 0.151 and 1.463 mg/L chloroform-treated fish had detectable amounts of chloroform, but these levels were always lower than the aquaria concentrations of chloroform. Thus, it appeared that chloroform did not bioaccumulate in the liver. Unidentified presumptive metabolite peaks were found in the GC tracings of these fish livers.
authors.affiliation: GEO-CENTERS, INC., Fort Detrick, Maryland 21702-5010, USA. Margaret.Toussaint@amedd.army.mil
authors.forename: M W
authors.initials: MW
authors.lastname: Toussaint
authors.forename: A B
authors.initials: AB
authors.lastname: Rosencrance
authors.forename: L M
authors.initials: LM
authors.lastname: Brennan
authors.forename: J R
authors.initials: JR
authors.lastname: Beaman
authors.forename: M J
authors.initials: MJ
authors.lastname: Wolfe
authors.forename: F J
authors.initials: FJ
authors.lastname: Hoffmann
authors.forename: H S
authors.initials: HS
authors.lastname: Gardner
mesh_terms: D000818:Animals; D000963:Antimetabolites / Q000008:administration & dosage; D001973:Bromodeoxyuridine / Q000008:administration & dosage; D002455:Cell Division / Q000187:drug effects*; D002725:Chloroform / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity*; D004202:Disinfectants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D008099:Liver / Q000737:chemistry / Q000187:drug effects*; D008113:Liver Neoplasms / Q000139:chemically induced; D009990:Oryzias / Q000502:physiology*; D014018:Tissue Distribution; D014881:Water Supply
chemical_list: D000963:Antimetabolites; D004202:Disinfectants; D002725:Chloroform; D001973:Bromodeoxyuridine